The DIMS annual report 2023 covers the concentrations, adulterations, and other relevant information produced by DIMS in the past year, and in doing so forms a topical image of the Dutch drug market. Spread out over all Dutch provinces, the DIMS network encompasses 32 testing-facilities providing nation-wide coverage. Together with these partners, DIMS aims to create a clear insight into the Dutch drug market, and signal potential health risks to the public.
